CHNO XV-XX Paris - CIC 1423
CHNO XV-XX Paris - CIC 1423
Paris, France3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Rod-Cone Dystrophy, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07807111 | |
| Promising ROd-cone DYstrophy Gene therapY | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-15 | NCT05748873 | |
| Prospective Natural History Study of Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, retinal degeneration, retinal disorder, retinitis pigmentosa, vision disorder | Active, not recruiting | Not applicable | 2025-05-22 | NCT04285398 |